Myanmar medical firm plans rare stock market entry amid ongoing civil unrest

A family-run business in Myanmar is moving forward with a share offering despite a raging civil war and a deep financial slump. Concordia Pcl aims to bring in roughly two hundred thousand dollars through this public offering, which marks a major milestone for the country's main stock exchange. The medical and engineering equipment supplier expects its shares to start trading between late December and early January, becoming the ninth firm on the main board of the Yangon exchange. Chairman Than Win stated that the move is designed to ready the enterprise for future expansion rather than secure immediate funds for growth. The company relies mostly on its own cash and carries very little debt. Strict import limits have caused severe delays, with some machinery taking over twelve years or more than a full year to arrive, prompting plans to shift toward local manufacturing. Specifically, the firm hopes to produce kidney dialysis supplies inside the country to avoid high shipping and customs expenses. Operations in the nation have faced heavy hurdles since the military takeover in twenty-twenty-one, including global trade restrictions and ongoing conflict. The local exchange remains heavily dominated by domestic participants, with local retail buyers making up ninety-nine point eighty-six percent of the market as of March. Exchange Chief Operating Officer Min Thu noted that trading interest has picked up this year, with plans for additional firms to join the exchange by next year.

Context

The Yangon Stock Exchange operates in a deeply challenging financial environment shaped by years of political turmoil and international isolation. While domestic retail traders make up nearly the entire market, exchange officials are looking toward a broader recovery when political and economic conditions eventually improve.